Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL3993021

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of ALK T1151-L1152 insT mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay
2
Total Activities
2
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R.
Mathi GR, Kang CH, Lee HK, Achary R, Lee HY, Lee JY, Ha JD, Ahn S, Park CH, Lee CO, Hwang JY, Yun CS, Jung HJ, Cho SY, Kim HR, Kim P.
Eur J Med Chem (2017) 126 : 536 -549
PubMed 27915169 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 2 9.20 9.20

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL2403108 CERITINIB 4.0 1 9.20
CHEMBL4099660 1 9.20

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL2403108 CERITINIB IC50 = 0.63 nM 9.20
CHEMBL4099660 IC50 = 0.63 nM 9.20